YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
cbdMD, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.35−0.01 (-2.22%)
Close on Oct 19, 2026
- Market cap
- $3.70M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.8019 (−69.73%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
cbdMD, Inc. grew revenue 10.0% to $20.93M over the twelve months to Jun 30, 2026. Free cash flow was -$2.41M.
Revenue
$20.93M
+10.0% vs. a year earlier
Operating income
-$2.90M
TTM Q3 2026
Free cash flow
-$2.41M
TTM Q3 2026
EPS, diluted
-$1.09
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.70M
- P/E ratio
- –
- Price to sales
- 0.18
- Price to book
- 0.45
- Dividend yield
- –
- Free cash flow yield
- -65.19%
Fundamentals
- Revenue
- $20.93M
- Net income
- -$2.89M
- EPS, diluted
- -$1.09
- Free cash flow
- -$2.41M
- Book value per share
- $0.77
- Diluted shares
- 11M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
$20.93M+10.0% YoY
Gross profit
$12.07M+3.7% YoY
Operating income
-$2.90M
Net income
-$2.89M
EPS, diluted
–
Free cash flow
-$2.41M
Reported periodTrailing twelve months